
Few treatment options exist for exposure to high doses of ionizing radiation over a short period of time, which would be expected following the meltdown of a nuclear reactor and other scenarios.
February 5, 2012
MD Becker Partners' newsletter covering the life science industry

Few treatment options exist for exposure to high doses of ionizing radiation over a short period of time, which would be expected following the meltdown of a nuclear reactor and other scenarios.

According to the National Institutes of Health’s [NIH] stem cell primer, stem cells have the ability to develop into many different cell types in the body during early life and growth. In many tissues they serve as an internal repair system, dividing essentially without limit to replenish other cells. When a stem cell divides, each [...]

The 2010 BMT Tandem Meetings were held in Orlando, Florida this past week [February 24-28, 2010]. Considered the premier event for hematopoietic cell transplantation [HCT] and cellular therapy, the annual event attracts more than 2,500 clinicians, transplant nurses, clinical research professionals, data managers, pharmacists, center administrators and mid-level practitioners. With more than 200 abstracts being [...]
Keynote address "Creating the methodological framework for cancer immunotherapy success" from MD Becker Partners' 2nd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference:
Life Science Digest is published by MD Becker Partners LLC, a boutique management and strategy consulting firm focusing on both public and private companies in the life science industry, including pharmaceuticals, biotechnology, and medical devices.
Interested in contributing articles to Life Science Digest? Send your request and a writing sample to: info@mdbpartners.com
Copyright © 2012 MD Becker Partners LLC · WordPress · Log in
Follow MD Becker Partners